Gossamer bio announces second quarter 2020 financial results and provides corporate update

Gossamer bio announces second quarter 2020 financial results and provides corporate update.q2 loss per share $1.00.q2 earnings per share estimate $-0.86 -- refinitiv ibes data.cash, cash equivalents and marketable securities totaled $600 million as of june 30, 2020.

GOSS Ratings Summary

GOSS Quant Ranking